Tojacia 5MG Tab

Composition

Tofacitinib (5mg)

Uses of Tojacia 5MG Tab

Treatment of moderate to severe rheumatoid arthritis (RA) in adults (especially when response to methotrexate is inadequate/intolerant); may be used alone or with methotrexate/other non-biologic DMARDs. Also used in certain inflammatory conditions as prescribed by a specialist (e.g., psoriatic arthritis, ulcerative colitis) based on clinical judgement and approval status.

• •Reduces joint pain and swelling in rheumatoid arthritis
• •Improves physical function and quality of life
• •Helps control inflammation and disease activity
• •May reduce progression of joint damage (with appropriate therapy)

How it works

Tofacitinib is a Janus kinase (JAK) inhibitor (primarily JAK1/JAK3) that reduces signaling of multiple cytokines involved in inflammation. This decreases immune overactivity and helps reduce joint pain, swelling, and progression of inflammatory damage.

Directions for use

Oral tablet. Take exactly as prescribed by the doctor, usually 5 mg twice daily (or as advised). Can be taken with or without food; swallow whole with water. Do not stop abruptly without medical advice; regular lab monitoring is required.

Side effects

Common side effects of Tojacia 5MG Tab may include:

• •Upper respiratory tract infection
• •headache
• •diarrhea